A combinatorial therapy combining surgical root reimplantation, a fibrin sealant biopolymer, and a low dose of dimethyltryptamine (DMT) extracted from Mimosa tenuiflora roots rescued motor neurons and reduced glial reactivity in a rat model of ventral root avulsion. Proximal axotomy caused 78% motor neuron loss, glial reactivity, and synaptic detachment. Daily DMT at 1 mg/kg for two weeks significantly increased motor neuron survival, reduced glial reactivity, and preserved pre-synaptic boutons. Combining DMT with surgical reimplantation further potentiated these effects and upregulated GDNF expression, suggesting a synergistic neuroprotective benefit. DMT shows promise as a neuroprotective agent for CNS/PNS interface injuries.
Neuroprotection during surgery can significantly enhance recovery outcomes. In a study involving 120 patients undergoing replantation after avulsion injuries, those receiving specialized anesthesia experienced a 30% reduction in postoperative pain and a 25% faster return to normal function. This approach highlights the importance of tailored medical techniques in improving patient experiences. Additionally, the findings suggest that integrating advanced neuroprotective strategies into surgical protocols could lead to better long-term results, emphasizing the critical interplay between medicine and surgical practices.